Cargando…
A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria
The use of iron supplementation for anemia in erythropoietic protoporphyria (EPP) is controversial with both benefit and deterioration reported in single case reports. There is no systematic study to evaluate the benefits or risks of iron supplementation in these patients. We assessed the potential...
Autores principales: | Balwani, Manisha, Naik, Hetanshi, Overbey, Jessica R., Bonkovsky, Herbert L., Bissell, D. Montgomery, Wang, Bruce, Phillips, John D., Desnick, Robert J., Anderson, Karl E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672425/ https://www.ncbi.nlm.nih.gov/pubmed/36406817 http://dx.doi.org/10.1016/j.ymgmr.2022.100939 |
Ejemplares similares
-
Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X‐linked protoporphyria
por: Naik, Hetanshi, et al.
Publicado: (2019) -
Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria
por: Dickey, Amy K., et al.
Publicado: (2020) -
How I treat erythropoietic protoporphyria and X-linked protoporphyria
por: Leaf, Rebecca Karp, et al.
Publicado: (2023) -
Erythropoietic protoporphyria
por: Lecha, Mario, et al.
Publicado: (2009) -
Advances in the management of erythropoietic protoporphyria – role of afamelanotide
por: Lane, Ashley M, et al.
Publicado: (2016)